Formosa Optical Technology (5312) Fundamentals 2026 — P/E 15.6x, Revenue Analysis | SniperIQ
Formosa Optical Technology (5312) is a TW-listed Healthcare company in Medical - Instruments & Supplies with a market capitalization of NT$5.5B, trading at NT$91.60 on the TWO. This SniperIQ fundamentals page covers Formosa Optical Technology's valuation (P/E 15.6x, P/B 1.4x), profitability (net margin 8.3%), revenue (NT$4.1B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Formosa Optical Technology's market cap?
Formosa Optical Technology (5312) has a market capitalization of approximately NT$5.5B, trading at NT$91.60 on the TWO. Market cap moves with the live share price.
What is Formosa Optical Technology's P/E ratio?
Formosa Optical Technology's trailing twelve-month P/E ratio is 15.6x, with a price-to-book (P/B) of 1.4x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Formosa Optical Technology?
Formosa Optical Technology runs a net profit margin of 8.3%, a gross margin of 63.7%, and an operating margin of 7.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Formosa Optical Technology generate?
Formosa Optical Technology reported revenue of NT$4.1B for fiscal year 2025, with net income of NT